|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Athenix Corporation Secures $13 Million In Series C Financing
1/6/2006 10:25:51 AM
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Jan. 6, 2006--Athenix Corp., a leading biotechnology company developing novel products, technologies, and processes for agricultural and chemical applications, announced today it has raised $13 million in growth capital through a Series C venture capital investment. The Series C round was led by new investor Finistere Partners of San Diego, California, with continued strong participation from the entire existing investor group: Intersouth Partners of Durham, North Carolina, Polaris Venture Partners of Waltham, Massachusetts, Boston Millennia Partners of Boston, Massachusetts, Hunt Ventures of Dallas, Texas, and Eastman Ventures, the venture capital arm of Eastman Chemical Company of Kingsport, Tennessee.
|
|
|
|
|
|
|
|
|
|
|